Online Journal
電子ジャーナル
IF値: 0.677(2017年)→0.966(2018年)

英文誌(2004-)

Journal of Medical Ultrasonics

一度このページでloginされますと,Springerサイト
にて英文誌のFull textを閲覧することができます.

cover

1996 - Vol.23

Vol.23 No.06

Original Article(原著)

(0423 - 0428)

超音波断層像による亜急性甲状腺炎の病期分類 −治療効果判定における臨床的有用性について−

Staging of Clinical Course of Subacute Thyroiditis by High Resolution Ultrasonography: A Study of Clinical Application on Treatment of Subacute Thyroiditis

石堂 晴美, 貴田岡 正史

Harumi ISHIDOH, Masafumi KITAOKA

公立昭和病院内分泌代謝科

Division of Endocrinology and Metabolism, Showa General Hospital

キーワード : Relapse, Staging, Steroid therapy, Subacute thyroditis, Ultrasonography

Subacute thyroiditis is a self-limiting disease that is sometimes managed effectively with steroid administration. Relapse is not always avoided, however, on cessation of steroid therapy. The main problem in the management of subacute thyroiditis is the absence of guideines for reducing dosage and terminating steroid therapy. High-resolution ultrasonography, a convenient method of imaging the diseased thyroid, may be able to provide these guidelines. We observed the clinical course of subacute thyroiditis through ultrasonographic images, and classified them into four stages based on their patterns. Decision of treatment procedure was based on these stages. The 12 patients in the control group received conventional treatment; treatment of the other 14 patients was based on ultrasonographic classification. Stage 1, the initial and most severe phase of inflanmmation, consists of thyroid swelling and large hypoechoic areas lacking clear margins. In this stage, 20 to 30 mg of prednisolone was administered. Stages 2 and 3, the phase of relatively improved inflammation, is characterized by localized hypoechoic changes. Dose of steroid was decreased 5 to 15 mg after each stage, and steroid administration was ceased once the condition reached stage 4, the recovery phase, which is characterized by almost normal ultrasonographic findings. Relapse rate was 58% in the controls, 14% in the classified groups; the management periods were 133.2 days and 71.3 days, respectively. Management based on ultrasonographic findings can decrease relapse rate and shorten clinical course of subacute thyroiditis. Our data speak for the clinical usefulness of using ultrasonography in staging treatment of subacute thyroiditis.